Regulation Of Cell Death Apoptotic Pathways By Nitric Oxide In Cancer: Reversal Of Drug/Immune Resistance

Tumor cells develop several mechanisms to avoid cell death by various unrelated cytotoxic agents. We have identified one such gene regulatory mechanism that inhibits, in large part, the cell death apoptotic pathways. This dysregulated mechanism is the result of several inter-related gene products th...

Full description

Bibliographic Details
Main Author: Benjamin Bonavida
Format: Article
Language:English
Published: Elsevier 2015-08-01
Series:Redox Biology
Online Access:http://www.sciencedirect.com/science/article/pii/S2213231715001275
id doaj-3a5e82de09594c39abb561992022b7ba
record_format Article
spelling doaj-3a5e82de09594c39abb561992022b7ba2020-11-25T01:54:58ZengElsevierRedox Biology2213-23172015-08-015415Regulation Of Cell Death Apoptotic Pathways By Nitric Oxide In Cancer: Reversal Of Drug/Immune ResistanceBenjamin Bonavida0Jonsson Comprehensive Cancer Center, University of California, Los Angeles, USATumor cells develop several mechanisms to avoid cell death by various unrelated cytotoxic agents. We have identified one such gene regulatory mechanism that inhibits, in large part, the cell death apoptotic pathways. This dysregulated mechanism is the result of several inter-related gene products that form a loop and consist of the NF-κB/Snail/YY1/RKIP/PTEN. The gene product expressions in this loop regulate the resistance to both chemotherapeutic drugs and cytotoxic immune lymphocytes/ligands. Briefly, the expressions and activities of NF-κB, Snail and YY1 are upregulated whereas the expressions and the activities of RKIP and PTEN are downregulated. The upregulated gene products are involved in the cell survival and growth and the expression of anti-apoptotic gene products; however, the downregulated gene products are involved in the inhibition of cell survival and anti-apoptotic gene products. The modulation of each of the gene products in the loop is sufficient to reverse resistance. We have found that treatment of tumor cells with high levels of NO donors resulted in the downregulation of the expression of NF-κB, Snail and YY1 while upregulation of RKIP and PTEN. Treatment with NO inhibited NF-κB, Snail and YY1 via s-nitrosylation. As repressors, their inhibition resulted in the upregulation of RKIP and PTEN. Subsequently, several anti-apoptotic gene products are inhibited by NO treatment as well as modifying the integrity of the mitochondria. Hence, treatment of resistant tumor cells with NO resulted in both the chemo and immunosensitization of tumor cells to apoptosis, in vitro and in vivo. The findings suggested the important role of NO donors as potential therapeutic sensitizing agents to reverse resistance.http://www.sciencedirect.com/science/article/pii/S2213231715001275
collection DOAJ
language English
format Article
sources DOAJ
author Benjamin Bonavida
spellingShingle Benjamin Bonavida
Regulation Of Cell Death Apoptotic Pathways By Nitric Oxide In Cancer: Reversal Of Drug/Immune Resistance
Redox Biology
author_facet Benjamin Bonavida
author_sort Benjamin Bonavida
title Regulation Of Cell Death Apoptotic Pathways By Nitric Oxide In Cancer: Reversal Of Drug/Immune Resistance
title_short Regulation Of Cell Death Apoptotic Pathways By Nitric Oxide In Cancer: Reversal Of Drug/Immune Resistance
title_full Regulation Of Cell Death Apoptotic Pathways By Nitric Oxide In Cancer: Reversal Of Drug/Immune Resistance
title_fullStr Regulation Of Cell Death Apoptotic Pathways By Nitric Oxide In Cancer: Reversal Of Drug/Immune Resistance
title_full_unstemmed Regulation Of Cell Death Apoptotic Pathways By Nitric Oxide In Cancer: Reversal Of Drug/Immune Resistance
title_sort regulation of cell death apoptotic pathways by nitric oxide in cancer: reversal of drug/immune resistance
publisher Elsevier
series Redox Biology
issn 2213-2317
publishDate 2015-08-01
description Tumor cells develop several mechanisms to avoid cell death by various unrelated cytotoxic agents. We have identified one such gene regulatory mechanism that inhibits, in large part, the cell death apoptotic pathways. This dysregulated mechanism is the result of several inter-related gene products that form a loop and consist of the NF-κB/Snail/YY1/RKIP/PTEN. The gene product expressions in this loop regulate the resistance to both chemotherapeutic drugs and cytotoxic immune lymphocytes/ligands. Briefly, the expressions and activities of NF-κB, Snail and YY1 are upregulated whereas the expressions and the activities of RKIP and PTEN are downregulated. The upregulated gene products are involved in the cell survival and growth and the expression of anti-apoptotic gene products; however, the downregulated gene products are involved in the inhibition of cell survival and anti-apoptotic gene products. The modulation of each of the gene products in the loop is sufficient to reverse resistance. We have found that treatment of tumor cells with high levels of NO donors resulted in the downregulation of the expression of NF-κB, Snail and YY1 while upregulation of RKIP and PTEN. Treatment with NO inhibited NF-κB, Snail and YY1 via s-nitrosylation. As repressors, their inhibition resulted in the upregulation of RKIP and PTEN. Subsequently, several anti-apoptotic gene products are inhibited by NO treatment as well as modifying the integrity of the mitochondria. Hence, treatment of resistant tumor cells with NO resulted in both the chemo and immunosensitization of tumor cells to apoptosis, in vitro and in vivo. The findings suggested the important role of NO donors as potential therapeutic sensitizing agents to reverse resistance.
url http://www.sciencedirect.com/science/article/pii/S2213231715001275
work_keys_str_mv AT benjaminbonavida regulationofcelldeathapoptoticpathwaysbynitricoxideincancerreversalofdrugimmuneresistance
_version_ 1724985873540317184